NITN | @notintownlive | 22 Apr 2022, 07:16 am

Bengaluru: South India’s diversified Sona Group has forged a 50:50 joint venture with Australia’s Mycelium Biotechnology Group to set up a state-of-the art Mycelium research and production facility in Salem.
Mycelium Biotechnology is an Australian group known for pioneering innovative solutions to optimise human and planetary health, using mycelium and other extracts from Mushrooms, an abundantly available and sustainable natural resource.
As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceuticals solutions through global partners.
According to Chocko Valliappa, Vice Chairman of The Sona group, “We are happy to forge the Mycelium Sona Biotech joint venture with Australia’s Mycelium Biotechnology, a research focused world leader in Mycelium based products and solution provider.
The partnership will leverage Sona Group’s research and innovation framework to add to the vast range of IP and patentable technologies.”
The JV named as Mycelium Sona Biotech (MSB) has set up a research facility at Salem to focus on Nanotech Research, IP development, Extract Manufacturing, Milling, Bottling and eCommerce. Billed as one of the largest mushrooms laboratories in India at Salem with best Global Manufacturing Practices, MSB laboratory will research and grow high end mushrooms, extract Mushroom and Mycelium compounds, produce nutraceuticals that conform to FSSAI and FDA certification.
“We see great opportunity in the Indian market moving forward. Sona’s background in health tech and research development is a perfect partnership for us to further advance our nano compound extraction IP.
The launch of the first MSB facility in Salem comes at the most opportune time soon after signing of the Free Trade Agreement between Australia and India” says William Scott, Chairman of Mycelium Biotechnology group.
With R&D, Business and Distribution centres located across Australia’s East Coast as well as manufacturing facilities in Wisconsin (USA), Mycelium Biotechnology owns scores of IP.
The bulk of this IP relates to cultivation methods and associated medium formulations for nearly 20 mushroom species, extraction processes of mushroom and mycelium biomass and formulations of mushroom extracts.
The medicinal mushroom industry is expected to grow exponentially as more and more of the 5.1 million mushroom species are researched.
The global fungi industry is forecast to exceed USD $86B by 2025, up from $53.7B in 2019. Growth will be powered in part by culinary demand, but an even larger driver will be rising adoption by the pharmaceutical industry.
Varieties such as Chaga, not ever seen on a dinner plate, are now in the supplement spotlight. www.thesonagroup.com
Some of the key portfolio companies expanding through the joint-venture include:
REMbiotics, one of the divisions of Mycelium Biotechnology, addresses the global issue of depression (MDD, TRD, PTSD) using specific mushroom mycelium bioactive compounds combined with Australian native bush foods for a beneficial and synergistic effect. www.rembiotics.com
Preotica is an evolutionary life sciences company that has been focusing on enhancing animal immunity and microbial health.
Utilising mycelium biotechnology extraction processes, the Preotica product has been able to produce some remarkable results, specifically in the poultry industry, aquaculture industry and for beekeepers across Australia. www.preotica.com.
Shroompac focuses on mushroom and mycelium-derived sustainable eco-packaging materials for industrial and consumer applications.
- MedSage expands footprint with new branch in Rampurhat
- Education for All reaches out to support marginalized children during Durga Puja
- A Defiant Voice Remembered: Jyotsna Mohan at The Write Circle, Dubai
- Rotary International District 3291 joins hands with JU, others to celebrate sustainable Durga Puja
- Saptak Music School of Pittsburgh hosts spellbinding evening of Indian classical music
- Kolkata: Ahiritola Yubak Brinda invites Auram to make jewellery for Ma Durga and her family
- Three-Day exhibition pays tribute to literary legends Sunil Gangopadhyay and Shakti Chattopadhyay
- Sona College’s sewing machines for differently-abled earn third patent
- Pt Tarun Bhattacharya joins eminent musicians in promoting young talents in Arizona
- Vijaya Diagnostic Centre inaugurates State-of-the-Art Centre featuring first advanced 3 Tesla MRI in Kolkata
Etihad Airways has launched its new A321LR aircraft on all flights to and from Kolkata, introducing a refined travel experience on the popular Indian route.
Etihad Airways is set to expand its global network with the addition of Damascus, the Syrian capital, as a new destination starting June 2026.
IndiGo and AEGEAN, the flag carrier of Greece, have signed a memorandum of understanding (MoU) for a codeshare partnership. The agreement, which is subject to regulatory approvals, will enable both carriers to offer flights on each other’s networks.